breastcancer.one ribbon markbreastcancer.oneRobot Assisted Breast Preservation
All articles

Considering Robotic Surgery · 24 Jul 2026

When Your UK Surgeon Says No to Robotic Breast Surgery

Being told you are not a candidate for robotic breast surgery can leave you with more questions than answers. This article explains the real clinical reasons behind that decision, which factors may change with treatment, and what practical options remain open to you.

8 min read

Medically reviewed by Dr Mandeep Singh Malhotra·Director, Surgical Oncology, CK Birla Hospital

When Your UK Surgeon Says No to Robotic Breast Surgery

If you're told you're not eligible for robotic breast surgery, it can be shocking. You may have spent hours reading about smaller cuts, faster healing, and better results. Then your surgeon said no - maybe without a clear reason why.

This article explains what that decision really means. It covers the medical factors surgeons consider for robotic breast surgery, which ones might change, and what you can do next. Not every patient is right for robotic techniques. But sometimes a different doctor or center gives a different answer.

What does "not eligible" really mean?

When a surgeon says you can't have robotic breast surgery, they're making a medical judgment based on your anatomy and tumor type. It's not about you as a person. It means one or more specific medical reasons make a robotic approach unsafe or not technically possible for you at that center.

The main reasons fall into three groups: the tumor itself, your breast anatomy, and your overall health. Knowing which group applies helps you see whether anything can change and what your real options are.

If you weren't given a clear reason, you can ask for one. Cancer Research UK notes that you have the right to ask for a second opinion, and most doctors will refer you if you request it.

The main reasons surgeons decline robotic breast surgery

A 2024 review published on the NIH database outlines the key eligibility rules for robotic nipple-sparing mastectomy. The most common reasons a patient may be declined include:

  • Tumor stage. Robotic nipple-sparing mastectomy is usually offered for stages I to IIIA. Locally advanced cancer - stage IIIB or higher - is typically not suitable. Inflammatory breast cancer, where cancer reaches the skin, is not done at most centers.
  • Tumor size and distance to the nipple. A tumor larger than 5 cm is often too large. A short distance between the tumor and the nipple-areolar complex has been a concern. However, a 2024 study on tumor-to-nipple distance suggests that 1 cm or less may not automatically rule out robotic surgery at experienced centers.
  • Nipple involvement. If cancer is confirmed at the nipple-areolar complex, nipple-preserving techniques won't work, no matter what surgical method is used.
  • Breast size and shape. Robotic nipple-sparing mastectomy works best in women with breasts up to roughly a C cup with minimal sagging. In larger or drooping breasts, blood flow to the nipple after surgery can be reduced, raising the risk of nipple tissue loss and poorer cosmetic results.
  • Skin or chest wall involvement. If cancer has spread to the skin over the breast or to the chest wall behind it, skin-preserving techniques are not safe.
  • Overall health factors. Significant heart, kidney, or liver problems can increase anesthesia risk. Some centers also caution heavy smokers, since poor circulation affects wound healing after minimally-invasive surgery.

These criteria are consistent across most major centers, but they're not always applied the same way. A reason that disqualifies you at one hospital may be assessed differently by a surgeon who does more robotic breast cases each year. This is a key reason to get a second opinion before committing to a conventional surgical plan.

What are the key factors that decide robotic breast surgery eligibility?

Common eligibility criteria for robotic nipple-sparing mastectomy and how they affect your case
FactorUsually eligibleMay be declined
Tumor stageStage I to IIIA; tumor up to 5 cmStage IIIB or later; inflammatory breast cancer
Nipple involvementNo cancer at the nipple-areolar complexConfirmed nipple-areolar involvement
Breast size and shapeUp to roughly C cup; minimal saggingLarger breasts or significant sagging
Skin and chest wallNo cancer in overlying skin or chest wallCancer in skin or chest wall
Overall healthFit for general anesthesia; no severe organ diseaseSignificant heart, liver, or kidney conditions

Source: NIH/PMC: Robotic-Assisted Nipple Sparing Mastectomy (2024)

This table shows general rules based on published evidence, not a personal checklist. One borderline factor doesn't automatically rule out robotic surgery everywhere. A surgeon who does more robotic procedures may assess your specific anatomy and tumor type quite differently than one who does only a few cases each year.

Which factors can change - and which won't?

Not every reason for being declined is permanent. Understanding which can change is important for your next steps.

Factors that may change include tumor size and lymph node involvement. Neoadjuvant therapy - chemotherapy or hormone treatment given before surgery to shrink cancer - may reduce a tumor that was initially too large for breast-conserving or nipple-sparing surgery. If tumor size or lymph node disease was the stated reason you were declined, ask your oncologist directly about pre-surgery treatment before you finalize a surgical plan.

Factors that rarely change include inflammatory breast cancer, which surgeons won't treat with nipple-preserving surgery at any center. Confirmed nipple involvement is also permanent: if cancer is present at the nipple-areolar complex on biopsy, keeping the nipple is not medically safe. Very large breast size or severe sagging is a relative but stable anatomical factor - though robotic skin-sparing mastectomy (which keeps the skin but not the nipple) may still be possible when nipple-sparing won't work.

To understand how these differences affect cosmetic and survival results, see our article on robotic nipple-sparing vs skin-sparing mastectomy outcomes.

Should you seek a second opinion?

A second opinion is a normal part of cancer decision-making. Macmillan Cancer Support confirms that you can ask for one and most cancer doctors will support this request. Your GP or specialist can refer you. Your imaging, biopsy results, and medical notes go to the new clinician.

A second opinion can confirm the original decision - giving you confidence to move forward. Or it can find something a more experienced surgeon sees differently, which might open up options your first center couldn't offer. Some women find that a surgeon who does more robotic breast cases takes a different view of a borderline factor like tumor-to-nipple distance or breast anatomy.

One practical note: Getting a second opinion through the NHS can take time because it's not treated as an urgent referral. If you need an answer quickly, a private or international second opinion might be faster and doesn't lock you into any choice.

If mastectomy is your only option, our article on getting a second opinion when mastectomy is recommended is helpful before you decide.

What if robotic mastectomy truly isn't possible for you?

If a full second assessment confirms robotic nipple-sparing mastectomy won't work for you, that's useful information. But other options are still available.

Skin-sparing mastectomy. If you can't keep your nipple, skin-sparing surgery keeps your natural skin and gives a more natural-looking result than standard mastectomy. Surgeons can do this robotically at specialist centers, or with regular surgery where robotic equipment isn't available.

Breast-conserving surgery (lumpectomy). For some patients, removing the tumor and surrounding tissue, then radiotherapy, works as well as mastectomy for certain cancer types and stages. If you haven't discussed this option fully, bring it up.

Neoadjuvant therapy before surgery. If your tumor is currently too large or too close to the nipple for a conservative approach, your oncologist may recommend pre-surgery treatment to shrink it. If the tumor shrinks enough, it might change what surgery becomes possible.

Oncoplastic surgery. This combines cancer removal with reconstruction in one surgery. Some NHS specialist centers and private hospitals offer this. You may get better shape and symmetry than with lumpectomy alone, and it's an option when robotic mastectomy won't work.

Does it matter where you have your assessment?

Robotic breast cancer surgery requires specific equipment - usually a da Vinci robotic system - and surgeons with real experience using it for breast procedures. Neither is available everywhere in the UK. NHS robotic programs have expanded, but breast-specific robotic surgery stays at a few specialist centers. Many hospital trusts use their robotic capacity for urology, gynecology, and colorectal surgery rather than breast surgery.

This means a surgeon who doesn't regularly do robotic breast surgery may have assessed you. That's not a criticism - it just shows where expertise is located in the UK system.

A growing number of UK women are getting assessments at dedicated breast cancer centers in India, where robotic nipple-sparing and skin-sparing mastectomy programs do more of these surgeries. Before you decide on UK surgery, the Art of Healing Cancer team can review your imaging and pathology reports remotely to see if robotic surgery is possible for you, without travel.

Some women choose to have surgery at a specialist center abroad and return home for chemotherapy or radiotherapy through their NHS team. Our article on splitting breast cancer care across two countries explains how this works in practice.

Questions to ask at your next appointment

Whether you're returning to your current surgeon, getting a second opinion, or speaking with a new team, these questions help you get what you need to decide:

  • Which specific factor or factors make me ineligible for robotic surgery right now?
  • Is this permanent, or could pre-surgery treatment change this?
  • Is skin-sparing mastectomy an option for me, even if nipple-sparing isn't?
  • What reconstruction options can be offered with mastectomy?
  • How many robotic breast operations does this center do each year?
  • Can you refer me for a second opinion if I want to explore this further?

You can arrange a private review of your case through BreastCancer.One, with support from coordinators.

When to talk to your doctor

Talk to your oncologist or surgeon right away if you weren't given a clear reason for being declined. Ask specifically about pre-surgery treatment if tumor size or lymph node disease was the stated reason. Get a second opinion for any surgery you're unsure about - your medical team can arrange this.

This article is for general information and educational purposes only. It is not a substitute for personalized medical advice from a qualified oncologist or your care team. Always consult your own doctors about your specific situation.

Frequently asked questions

Surgeons consider several factors when assessing robotic breast surgery candidacy, including tumour stage and size, breast anatomy such as breast size and degree of drooping (ptosis), whether the nipple-areolar complex is involved, skin or chest wall involvement, and overall health. Robotic nipple-sparing mastectomy is generally offered for stages I to IIIA with tumours up to 5 cm. If one or more factors falls outside the usual criteria at that centre, a surgeon may recommend a conventional approach instead.

Yes. You are entitled to ask for a second opinion and most cancer doctors will refer you if asked. Your GP or specialist can make the referral, and your scans, biopsy results, and medical notes will be shared with the second clinician. If NHS waiting times are a concern, a private or international second opinion can also provide a faster answer without committing you to any particular surgical plan.

In some cases, yes. Neoadjuvant chemotherapy or hormone therapy given before surgery can shrink a tumour. If the tumour was initially too large or too close to the nipple for a minimally-invasive approach, a good response to pre-surgery treatment may shift the candidacy picture. This should be discussed with your oncology team based on your specific tumour type, biology, and response to therapy.

Robotic surgery has expanded across NHS trusts, but dedicated robotic breast cancer programmes remain concentrated at a small number of specialist centres. Many NHS trusts focus their robotic capacity on urology, gynaecology, and colorectal surgery rather than breast procedures. If your local centre does not offer robotic breast surgery, a referral to a specialist centre or an assessment at a private or international hospital may give you a fuller picture of what is possible in your case.

Several alternatives may be suitable depending on your specific situation. These include skin-sparing mastectomy with immediate reconstruction, conventional nipple-sparing mastectomy at centres with the relevant surgical experience, breast-conserving surgery (lumpectomy) followed by radiotherapy, oncoplastic surgery combining tumour removal with reconstructive techniques in one operation, and - if tumour size is the issue - neoadjuvant therapy to shrink the cancer before reassessing your surgical options. Your breast surgical team can advise which approach best fits your case.

Tumour-to-nipple distance is the measured gap between the cancer and the nipple-areolar complex. A short distance has traditionally been used as a reason to remove the nipple during mastectomy. However, more recent evidence from 2024 suggests that a distance of 1 cm or less may not automatically rule out nipple-sparing approaches at specialist centres, particularly when an intraoperative biopsy of nipple tissue is taken during surgery to confirm that no cancer cells are present.

Have a question about your own case?

Speak with our team confidentially - share your reports and we'll help you understand your options.

Book a consultation